ME Therapeutics Holdings Inc.
METX
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 236.63% | 131.98% | 160.52% | -- | 391.61% |
| Total Receivables | -16.67% | 132.08% | 113.33% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 40.98% | 46.09% | 66.67% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 195.82% | 129.77% | 159.77% | -- | -- |
|
|
|||||
| Total Current Assets | 195.82% | 129.77% | 159.77% | -- | -- |
| Net Property, Plant & Equipment | 79,700.00% | 0.00% | -50.00% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 220.99% | 129.74% | 159.68% | -- | -- |
|
|
|||||
| Total Accounts Payable | 135.90% | -56.60% | -81.64% | -- | -- |
| Total Accrued Expenses | 2,190.00% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.15% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 853.85% | 3.85% | -- | -- |
| Total Other Current Liabilities | -- | 853.85% | 3.85% | -- | -- |
| Total Current Liabilities | 116.58% | -57.52% | -60.62% | -- | -- |
|
|
|||||
| Total Current Liabilities | 116.58% | -57.52% | -60.62% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 187.39% | -57.52% | -60.62% | -- | -- |
|
|
|||||
| Common Stock & APIC | 30.89% | 35.52% | 38.07% | -- | -- |
| Retained Earnings | -12.88% | -18.25% | -90.73% | -- | -- |
| Treasury Stock & Other | 13.70% | 20.72% | 811.55% | -- | -- |
| Total Common Equity | 227.72% | 182.88% | 209.57% | -- | 397.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 227.72% | 182.88% | 209.57% | -- | 397.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 227.72% | 182.88% | 209.57% | -- | 397.63% |
|
|
|||||
